The demand for medication to be delivered using autoinjectors is rising internationally, responding to the increased incidence rates of chronic conditions and the emerging treatments for those chronic conditions. Autoinjectors are used to deliver medication to treat Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Crohn’s Disease, among others. It is reasonable to assume that some autoinjector users will have previously used syringes, pen-injectors or other types of autoinjectors (e.g., emergency-use autoinjectors).
The challenge of negative transfer in device use
Negative transfer is a potential cause of use errors and difficulties during device interactions. Negative transfer occurs when a user assumes how a device is going to work based on their experience with similar devices or similar device components. Below, we consider the negative transfer these individuals could experience when using autoinjectors.
Understanding Negative Transfer in Autoinjectors | Emergo by UL
Negative Transfer During Autoinjector Use: Common Issues
Discover how transfer affects autoinjector users transitioning from syringes, pen-injectors, or emergency devices and learn strategies to address these challenges in product design for safer medication delivery.
www.emergobyul.com
